Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Heart Defect Closure Devices Market by Defect Type (Atrial Septal Defect Closure Devices, Left Atrial Appendage Closure Devices, Patent Foramen Ovale Closure Devices, Patent Ductus Arteriosus Closure Devices, Ventricular Septal Defect Closure Devices) and by End User (Hospitals, Clinics): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04140

Pages: NA

Charts: NA

Tables: NA

Heart defects closure devices are medical devices used for diagnosis and treatment of congenital heart defect, which include atrial septal defect, ventricular septal defect, left atrial appendage defect, and patent ductus arteriosus. These defects appear in the structure of the heart, which results in interference of normal flow of blood through the heart. Closure devices are employed to close an opening between right and left sides of the heart, thus treating congenital heart defects. 

Increase in incidence of congenital heart defects, upsurge in geriatric population, technological advancements in heart closure devices, and rise in adoption of MRI procedures are the key factors that drive the growth of the global heart defect closure devices market. However, high cost of production and stringent regulations associated with these devices restrain the market growth. On the contrary, increase in number of heart strokes and development of innovative products by key players are expected to provide remunerative opportunities for market expansion in the near future.

The utilization of 3D imaging and anatomical models in the manufacturing and planning processes of heart defect closure devices is gaining prominence in the market. This is expected to change the supply landscape of the industry, owing to characteristics such as personalization, adaptability, and flexibility provided by using 3D imaging technology. This in turn decreases the overall prostheses employed per patient along with the procedure time, which makes it a viable option in the production and planning process.

The global heart defects closure devices market is segmented into defect type, end user, and region. On the basis of defect type, the market is divided into atrial septal defect closure devices, left atrial appendage closure devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, and ventricular septal defect closure devices. By end user, it is classified into hospitals, and clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global heart defects closure devices market include Medtronic Plc., Boston Scientific Corporation, St. Jude Medical, Inc., W. L. Gore & Associates, Inc., Biosense Webster, Inc., Lifetech Scientific, Starway Medical Technology, Inc., Cardia, Inc., Occlutech Holding AG, and SentreHEART, Inc.

Key Benefits for Stakeholders 

  • The study provides an in-depth analysis of the global heart defects closure devices market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.

 Key Market Segments

  • By Defect Type
    • Atrial Septal Defect Closure Devices
    • Left Atrial Appendage Closure Devices
    • Patent Foramen Ovale Closure Devices
    • Patent Ductus Arteriosus Closure Devices
    • Ventricular Septal Defect Closure Devices
  • By End User
    • Hospitals
    • Clinics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Occlutech Holding AG
  • Starway Medical Technology, Inc.
  • Inc., Biosense Webster, Inc.
  • Boston Scientific Corporation
  • SentreHEART, Inc.
  • Medtronic Plc.
  • Lifetech Scientific
  • Cardia, Inc.
  • St. Jude Medical, Inc.
  • W. L. Gore & Associates

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: HEART DEFECT CLOSURE DEVICES MARKET, BY DEFECT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Defect Type

    • 4.2. Atrial Septal Defect Closure Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Left Atrial Appendage Closure Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Patent Foramen Ovale Closure Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Patent Ductus Arteriosus Closure Devices

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Ventricular Septal Defect Closure Devices

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: HEART DEFECT CLOSURE DEVICES MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: HEART DEFECT CLOSURE DEVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Defect Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Heart Defect Closure Devices Market

        • 6.2.5.1. Market Size and Forecast, By Defect Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Heart Defect Closure Devices Market

        • 6.2.6.1. Market Size and Forecast, By Defect Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Heart Defect Closure Devices Market

        • 6.2.7.1. Market Size and Forecast, By Defect Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Defect Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Heart Defect Closure Devices Market

        • 6.3.5.1. Market Size and Forecast, By Defect Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Heart Defect Closure Devices Market

        • 6.3.6.1. Market Size and Forecast, By Defect Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Heart Defect Closure Devices Market

        • 6.3.7.1. Market Size and Forecast, By Defect Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Heart Defect Closure Devices Market

        • 6.3.8.1. Market Size and Forecast, By Defect Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Heart Defect Closure Devices Market

        • 6.3.9.1. Market Size and Forecast, By Defect Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Heart Defect Closure Devices Market

        • 6.3.10.1. Market Size and Forecast, By Defect Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Heart Defect Closure Devices Market

        • 6.3.11.1. Market Size and Forecast, By Defect Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Defect Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Heart Defect Closure Devices Market

        • 6.4.5.1. Market Size and Forecast, By Defect Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Heart Defect Closure Devices Market

        • 6.4.6.1. Market Size and Forecast, By Defect Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Heart Defect Closure Devices Market

        • 6.4.7.1. Market Size and Forecast, By Defect Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Heart Defect Closure Devices Market

        • 6.4.8.1. Market Size and Forecast, By Defect Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Heart Defect Closure Devices Market

        • 6.4.9.1. Market Size and Forecast, By Defect Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Heart Defect Closure Devices Market

        • 6.4.10.1. Market Size and Forecast, By Defect Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Heart Defect Closure Devices Market

        • 6.4.11.1. Market Size and Forecast, By Defect Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Heart Defect Closure Devices Market

        • 6.4.12.1. Market Size and Forecast, By Defect Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Heart Defect Closure Devices Market

        • 6.4.13.1. Market Size and Forecast, By Defect Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Defect Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Heart Defect Closure Devices Market

        • 6.5.5.1. Market Size and Forecast, By Defect Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Heart Defect Closure Devices Market

        • 6.5.6.1. Market Size and Forecast, By Defect Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Heart Defect Closure Devices Market

        • 6.5.7.1. Market Size and Forecast, By Defect Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Heart Defect Closure Devices Market

        • 6.5.8.1. Market Size and Forecast, By Defect Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Heart Defect Closure Devices Market

        • 6.5.9.1. Market Size and Forecast, By Defect Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Heart Defect Closure Devices Market

        • 6.5.10.1. Market Size and Forecast, By Defect Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Medtronic Plc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Boston Scientific Corporation

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. St. Jude Medical, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. W. L. Gore And Associates

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Inc., Biosense Webster, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Lifetech Scientific

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Starway Medical Technology, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Cardia, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Occlutech Holding AG

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. SentreHEART, Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR ATRIAL SEPTAL DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR PATENT FORAMEN OVALE CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR PATENT DUCTUS ARTERIOSUS CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR VENTRICULAR SEPTAL DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA HEART DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. U.S. HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 15. U.S. HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. CANADA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. CANADA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE HEART DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. ITALY HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. ITALY HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. UK HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. UK HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC HEART DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. CHINA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. CHINA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. INDIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. INDIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA HEART DEFECT CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. UAE HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. UAE HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA HEART DEFECT CLOSURE DEVICES, BY DEFECT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA HEART DEFECT CLOSURE DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 74. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 75. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 76. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 77. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 79. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 80. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 81. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. ST. JUDE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 84. ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 85. ST. JUDE MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 86. ST. JUDE MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 87. ST. JUDE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. W. L. GORE AND ASSOCIATES: KEY EXECUTIVES
  • TABLE 89. W. L. GORE AND ASSOCIATES: COMPANY SNAPSHOT
  • TABLE 90. W. L. GORE AND ASSOCIATES: OPERATING SEGMENTS
  • TABLE 91. W. L. GORE AND ASSOCIATES: PRODUCT PORTFOLIO
  • TABLE 92. W. L. GORE AND ASSOCIATES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. INC., BIOSENSE WEBSTER, INC.: KEY EXECUTIVES
  • TABLE 94. INC., BIOSENSE WEBSTER, INC.: COMPANY SNAPSHOT
  • TABLE 95. INC., BIOSENSE WEBSTER, INC.: OPERATING SEGMENTS
  • TABLE 96. INC., BIOSENSE WEBSTER, INC.: PRODUCT PORTFOLIO
  • TABLE 97. INC., BIOSENSE WEBSTER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. LIFETECH SCIENTIFIC: KEY EXECUTIVES
  • TABLE 99. LIFETECH SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 100. LIFETECH SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 101. LIFETECH SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 102. LIFETECH SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. STARWAY MEDICAL TECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 104. STARWAY MEDICAL TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 105. STARWAY MEDICAL TECHNOLOGY, INC.: OPERATING SEGMENTS
  • TABLE 106. STARWAY MEDICAL TECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 107. STARWAY MEDICAL TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. CARDIA, INC.: KEY EXECUTIVES
  • TABLE 109. CARDIA, INC.: COMPANY SNAPSHOT
  • TABLE 110. CARDIA, INC.: OPERATING SEGMENTS
  • TABLE 111. CARDIA, INC.: PRODUCT PORTFOLIO
  • TABLE 112. CARDIA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. OCCLUTECH HOLDING AG: KEY EXECUTIVES
  • TABLE 114. OCCLUTECH HOLDING AG: COMPANY SNAPSHOT
  • TABLE 115. OCCLUTECH HOLDING AG: OPERATING SEGMENTS
  • TABLE 116. OCCLUTECH HOLDING AG: PRODUCT PORTFOLIO
  • TABLE 117. OCCLUTECH HOLDING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. SENTREHEART, INC.: KEY EXECUTIVES
  • TABLE 119. SENTREHEART, INC.: COMPANY SNAPSHOT
  • TABLE 120. SENTREHEART, INC.: OPERATING SEGMENTS
  • TABLE 121. SENTREHEART, INC.: PRODUCT PORTFOLIO
  • TABLE 122. SENTREHEART, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HEART DEFECT CLOSURE DEVICES MARKET
  • FIGURE 3. SEGMENTATION HEART DEFECT CLOSURE DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HEART DEFECT CLOSURE DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEART DEFECT CLOSURE DEVICES MARKET
  • FIGURE 11. HEART DEFECT CLOSURE DEVICES MARKET SEGMENTATION, BY BY DEFECT TYPE
  • FIGURE 12. HEART DEFECT CLOSURE DEVICES MARKET FOR ATRIAL SEPTAL DEFECT CLOSURE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. HEART DEFECT CLOSURE DEVICES MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. HEART DEFECT CLOSURE DEVICES MARKET FOR PATENT FORAMEN OVALE CLOSURE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. HEART DEFECT CLOSURE DEVICES MARKET FOR PATENT DUCTUS ARTERIOSUS CLOSURE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. HEART DEFECT CLOSURE DEVICES MARKET FOR VENTRICULAR SEPTAL DEFECT CLOSURE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. HEART DEFECT CLOSURE DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. HEART DEFECT CLOSURE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. HEART DEFECT CLOSURE DEVICES MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: HEART DEFECT CLOSURE DEVICES MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ST. JUDE MEDICAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ST. JUDE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ST. JUDE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. W. L. GORE AND ASSOCIATES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. W. L. GORE AND ASSOCIATES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. W. L. GORE AND ASSOCIATES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. INC., BIOSENSE WEBSTER, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. INC., BIOSENSE WEBSTER, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. INC., BIOSENSE WEBSTER, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. LIFETECH SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. LIFETECH SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. LIFETECH SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. STARWAY MEDICAL TECHNOLOGY, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. STARWAY MEDICAL TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. STARWAY MEDICAL TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. CARDIA, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. CARDIA, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. CARDIA, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. OCCLUTECH HOLDING AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. OCCLUTECH HOLDING AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. OCCLUTECH HOLDING AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. SENTREHEART, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. SENTREHEART, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. SENTREHEART, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Heart Defect Closure Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved